Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	-0,02%	-0,07%	-1,03%	+13,55%	48,22 mld.
REVOLUTION MEDICINES, INC.	-2,71%	-2,99%	+398,09%	+472,12%	38,79 mld.
IQVIA HOLDINGS INC.	-0,71%	+9,45%	+27,90%	+7,89%	38,41 mld.
BEONE MEDICINES AG	-0,71%	-3,72%	+4,94%	+52,45%	34,88 mld.
CELLTRION, INC.	-2,41%	+1,96%	+11,68%	+38,17%	29,19 mld.
MEDPACE HOLDINGS, INC.	-0,66%	-2,73%	+35,50%	+122,17%	16 mld.
ASCENDIS PHARMA A/S	-0,19%	-3,93%	-	-	16,05 mld.
EUROFINS SCIENTIFIC SE	+0,77%	-0,38%	+2,58%	+15,85%	13,53 mld.
ICON PUBLIC LIMITED COMPANY	-3,15%	-6,14%	-4,82%	-36,90%	12,22 mld.
Gemiddelde	-0,98%	-0,66%	+59,36%	+85,66%	27,48 mld.
Gewogen gemiddelde per kap.	-1,09%	+0,15%	+75,77%	+103,49%

Werknemers

Sector